Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    11468499 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their Parents
Condition: ADA-SCID
Intervention:
2 Completed Health-related Quality of Life Measure in Pediatric Lupus
Conditions: Systemic Lupus Erythematosus;   Quality of Life
Intervention:
3 Recruiting A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
Condition: AADC Deficiency
Intervention: Drug: AAV2-hAADC
4 Active, not recruiting Efficacy of Motivational Interview in the Treatment of Obesity and Overweight in Adolescents
Condition: Obesity
Interventions: Behavioral: Motivational Interview;   Behavioral: Conventional Interview
5 Recruiting Finding the Optimum Regimen for Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Prednisone;   Drug: Deflazacort
6 Enrolling by invitation Quality of Life in Pediatric Transplant Patients
Conditions: Kidney Transplantation;   Liver Transplantation;   Heart Transplantation
Intervention:
7 Completed Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI
Conditions: Cystic Fibrosis;   Pancreatic Insufficiency
Interventions: Dietary Supplement: Lym-X-Sorb powder;   Dietary Supplement: Placebo powder

Study has passed its completion date and status has not been verified in more than two years.